NCT02437071 2025-12-05Assess the Efficacy of Pembrolizumab Plus Radiotherapy or Ablation in Metastatic Colorectal Cancer PatientsMemorial Sloan Kettering Cancer CenterPhase 2 Completed34 enrolled 10 charts